BioCardia to Host Q3 2023 Corporate Update and Financial Results Conference Call on November 8, 2023
November 01, 2023 17:04 ET
|
BioCardia, Inc.
SUNNYVALE, Calif., Nov. 01, 2023 (GLOBE NEWSWIRE) -- BioCardia®, Inc. [NASDAQ:BCDA], a developer of cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary diseases,...